⌘K
Loading ticker…
Candel Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Candel Therapeutics, Inc. Common Stock (CADL) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 77. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.1%, relative volume 2.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 96, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
CADL is in a stage 2 uptrend, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 23.0% / 63.2%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
CADL is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $10M notional. Top 3 carry $17M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $10M |
| IWMiShares Russell 2000 ETF | 0.01% | $5M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CADL Jan avg: 4.20% median: -4.10% win: 50% σ: 27.78% n: 4 2022-04-12 → 2026-05-29 | CADL Feb avg: 7.49% median: 8.42% win: 50% σ: 33.45% n: 4 2022-04-12 → 2026-05-29 | CADL Mar avg: -20.94% median: -20.03% win: 0% σ: 13.09% n: 4 2022-04-12 → 2026-05-29 | CADL Apr avg: 64.94% median: -4.44% win: 40% σ: 158.55% n: 5 2022-04-12 → 2026-05-29 | CADL May avg: 18.78% median: 17.05% win: 100% σ: 11.64% n: 5 2022-04-12 → 2026-05-29 | CADL Jun avg: -17.03% median: -15.31% win: 0% σ: 9.72% n: 4 2022-04-12 → 2026-05-29 (current) | CADL Jul avg: 1.10% median: -4.34% win: 25% σ: 18.13% n: 4 2022-04-12 → 2026-05-29 | CADL Aug avg: 7.14% median: 12.45% win: 75% σ: 11.56% n: 4 2022-04-12 → 2026-05-29 | CADL Sep avg: -10.84% median: -10.71% win: 25% σ: 11.17% n: 4 2022-04-12 → 2026-05-29 | CADL Oct avg: -14.68% median: -13.00% win: 25% σ: 20.00% n: 4 2022-04-12 → 2026-05-29 | CADL Nov avg: -8.03% median: -10.34% win: 0% σ: 5.33% n: 4 2022-04-12 → 2026-05-29 | CADL Dec avg: 42.18% median: 40.98% win: 100% σ: 38.30% n: 4 2022-04-12 → 2026-05-29 |